Edwards Lifesciences Corporation (EW) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$83.20
Price Target
$96.53
Target Range
$85.00 — $110.00
Analyst Rating
Buy
Forward P/E27.7x
Trailing P/E45.5x
Forward PEG3.91
Implied Growth+63.5%
Median Target$95.00
Analyst Spread25.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$85
+2.2%
Consensus
$97
+16.0%
Bull Case
$110
+32.2%
Valuation Model TargetsConfidence: 68/100
Bear$149
Base$155
Bull$299
EW Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Edwards Lifesciences Corporation (EW) has a Wall Street consensus price target of $96.53, based on estimates from 48 covering analysts. With the stock currently trading at $83.20, this represents a potential upside of +16.0%. The company has a market capitalization of $47.97B.
Analyst price targets range from a low of $85.00 to a high of $110.00, representing a 26% spread in expectations. The median target of $95.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 32 analysts rating the stock as a Buy or Strong Buy,16 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, EW trades at a trailing P/E of 45.5x and forward P/E of 27.7x. The forward PEG ratio of 3.91 reflects a premium valuation. Analysts expect EPS to grow +63.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $154.78, with bear and bull scenarios of $149.07 and $299.32 respectively. Model confidence stands at 68/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+138.6%
Avg Forward P/E74.9x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 SYKStryker Corporation | $112.0B | $292.33 | $403.69 | +38.1% | Buy | 19.5x | 50 |
 ZBHZimmer Biomet Holdings, Inc. | $16.2B | $82.83 | $97.90 | +18.2% | Hold | 9.8x | 42 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 ATRCAtriCure, Inc. | $1.4B | $28.01 | $50.67 | +80.9% | Buy | 373.5x | 19 |
 NTRANatera, Inc. | $29.6B | $215.09 | $262.50 | +22.0% | Buy | — | 27 |
 NNOXNano-X Imaging Ltd. | $117M | $1.79 | $18.00 | +905.6% | Buy | — | 5 |
 IRTCiRhythm Technologies, Inc. | $3.9B | $117.70 | $193.67 | +64.5% | Buy | — | 19 |
Upside Potential Comparison
NNOXNVCRATRCIRTCBSXABTMDTSYKFull EW Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See EW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEW — Frequently Asked Questions
Quick answers to the most common questions about buying EW stock.
What is the EW stock price target for 2026?
Edwards Lifesciences Corporation (EW) has a consensus 12-month price target of $96.53, implying 16.0% upside from $83.2. The 48 analysts covering EW see moderate appreciation potential.
Is EW a buy, sell, or hold?
EW has a consensus rating of "Buy" based on 48 Wall Street analysts. The rating breakdown is predominantly bullish, with 32 Buy/Strong Buy ratings. The consensus 12-month price target of $96.53 implies 16.0% upside from current levels.
Is EW stock overvalued or undervalued?
EW trades at a forward P/E of 27.6651x, representing a moderate valuation. With analysts targeting $96.53 (16.0% implied move), the stock appears reasonably valued with upside.
How high can EW stock go?
The most bullish Wall Street analyst has a price target of $110 for EW, while the most conservative target is $85. The consensus of $96.53 represents the median expectation. Our quantitative valuation model projects a bull case target of $299 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover EW stock?
EW is heavily covered by Wall Street, with 48 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 32 have Buy ratings, 16 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the EW stock forecast?
The 12-month EW stock forecast based on 48 Wall Street analysts shows a consensus price target of $96.53, with estimates ranging from $85 (bear case) to $110 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $155, with bear/bull scenarios of $149/$299.
What is EW's fair value based on fundamentals?
Our quantitative valuation model calculates EW's fair value at $155 (base case), with a bear case of $149 and bull case of $299. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 68/100.
What is EW's forward P/E ratio?
EW trades at a forward P/E ratio of 27.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 45.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy EW stock?
Wall Street analysts are optimistic on EW, with a "Buy" consensus rating and $96.53 price target (16.0% upside). 32 of 48 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do EW price targets vary so much?
EW analyst price targets range from $85 to $110, a 26% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $96.53 consensus represents the middle ground. Our model's $149-$299 range provides an independent fundamental perspective.